In colorectal cancer, Coleman et al. noted acute (and chronic) ATF6 activation as leading to the upregulation of Fasn and fatty acid biosynthesis, with lysophospholipids and long-chain fatty acids (LCFA) being the most prominent lipid metabolites [176]. This evidence concerns the gene ATF6 and colorectal cancer.